As of 2024-12-12, the Fair Value of Relay Therapeutics Inc (RLAY) is -18.03 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.98 USD, the upside of Relay Therapeutics Inc is -462.11%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -75.31 | -52.41 | -363.87 | -290.51 | -341.97 | -224.81 |
| YoY growth | -54.36% | 30.41% | -594.28% | 20.16% | -17.71% | -123.16% |
| Market Cap (mil) | 833.55 |
| P/E | |
| Forward P/E |
| EPS | -3.61 |
| Avg earnings growth rate | -123.16% |
| TTM earnings | -603.68 |